A recent NBC News article discussed Pfizer’s plans to submit data to the FDA for a fourth dose of its COVID-19 vaccine. As Pfizer CEO Albert Bourla put it to CNBC in an interview last Friday, “Clearly there is a need in an environment of omicron to boost the immune response.” Pfizer’s scientists are seeing that the initial booster’s protection against omicron is beginning to wane after three to four months, suggesting a need for a fourth dose.
Pfizer Nears Submitting Data to FDA for 4th COVID-19 Shot
Omicron-related cases are down significantly, but certain groups may still need additional vaccine protection.
Mar 17, 2022
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
